Harwell’s HealthTec cluster is home to some of the leading life science organisations in the world.
With over 1000 people dedicated to healthcare and its related fields, Harwell’s HealthTec cluster is a global force. The cluster draws on the campus’s diverse expertise to deliver world firsts and life-changing innovations.
By combining the multidisciplinary capabilities available on campus, the cluster is engaged in cellular and structural biology, pharmacology, big data, advanced materials, and more.
Our vision is to develop the Harwell HealthTec cluster into an innovation hub that becomes the world leader in the research and application of physical and life sciences.
Advancements in all areas of healthcare are increasingly dependent on the cross fertilisation of ideas across different fields and this is one reason why I am so excited by the development of the HealthTec Cluster at Harwell.
Professor Sir John Bell
Regius Professor of Medicine University of Oxford
At Harwell, the HealthTec cluster is located a stone’s throw away from:
- World-leading large-scale science facilities and their associated technologies, expertise and capabilities
- A diverse range of R&D activity related to life sciences
- Public sector, academic and industrial organisations working together to accelerate the practical application of research
- An investment network with multiple sources of funding, both public and private sector
The HealthTec cluster boasts capabilities and skills in areas including:
- Medical, genetics, genomics and therapeutics
- Pharmacology, microbiology, cell and structural biology
- Environmental health
- Big data
- Advanced materials & nanotechnology
GSK has benefited from engagement with the specialists at the world leading research facilities at the Harwell Campus. We have found the experts there to have an industry friendly approach to working with us, which accelerates innovation within our drug discovery programmes. We view the growing HealthTec cluster at Harwell as playing an increasingly important part in the UK’s innovation landscape.
Dr Malcolm Skingle
Director of Academic Liaison, GSK